Skip to main content
CellSeed Inc. logo

CellSeed Inc. — Investor Relations & Filings

Ticker · 7776 ISIN · JP3423530009 T Manufacturing
Open in API
Filings indexed 65 across all filing types
Latest filing 2016-11-14 Interim / Quarterly Rep…
Country JP Japan
Listing T 7776

About CellSeed Inc.

https://www.cellseed.com/en/

CellSeed Inc. is a regenerative medicine company centered on the research, development, and commercialization of its proprietary "cell sheet engineering" technology. This innovative platform enables the creation and harvesting of intact sheets of cultured cells without enzymatic treatment, preserving the extracellular matrix and cell-to-cell junctions critical for therapeutic efficacy. The company's business is structured around three core activities: the development of its own pipeline of cell sheet-based therapies for tissue regeneration, the sale of specialized temperature-responsive cell cultureware and related equipment, and the provision of contract development and manufacturing (CDMO) services for regenerative medicine products.

Recent filings

Filing Released Lang Actions
四半期報告書－第16期第3四半期(2016/07/01－2016/09/30)
Interim / Quarterly Report
2016-11-14 Japanese
四半期報告書－第16期第2四半期(2016/04/01－2016/06/30)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) for CellSeed Inc., covering the period from April 1, 2016, to June 30, 2016. It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement, as well as management analysis of financial conditions and results of operations. This fits the definition of an Interim/Quarterly Report (IR). H1 2016
2016-08-15 Japanese
四半期報告書－第16期第1四半期(2016/01/01－2016/03/31)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) for the first quarter of the 16th fiscal year (January 1, 2016 to March 31, 2016) for CellSeed Inc. It contains detailed financial statements, including the balance sheet, income statement, and segment information, as required by the Financial Instruments and Exchange Act of Japan. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2016
2016-05-16 Japanese
有価証券報告書－第15期(2015/01/01－2015/12/31)
Annual Report
2016-03-30 Japanese
四半期報告書－第15期第3四半期(2015/07/01－2015/09/30)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) for the third quarter of the 15th fiscal period, filed by CellSeed Inc. with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It contains detailed financial statements, management analysis (MD&A), and information on share capital and stock options. This fits the definition of an Interim/Quarterly Report (IR) as it provides comprehensive financial data for a period shorter than a full fiscal year. 9M 2015
2015-11-16 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.